Skip to content

13F-HR filed by Aquilo Capital Management, LLC

Aquilo Capital Management, LLC filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-14, with 14 holding rows worth $131,875,058.

Accession
0001591986-24-000007
Filed
2024-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2024

A holdings report, 14 entries on the cover page, a total value of $131,875,058 stated on the cover page (in dollars after the unit check, H1), rows summing to $131,875,058 with VALUE read as dollars as filed, 13F file number 028-18892. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS75,000$43,032,000dollars as filedput
ARROWHEAD PHARMACEUTICALS IN04280A100COM795,813$15,414,898dollars as filed
BLUEPRINT MEDICINES CORP09627Y109COM124,600$11,525,500dollars as filed
KYMERA THERAPEUTICS INC501575104COM208,743$9,879,806dollars as filed
REGENXBIO INC75901B107COM930,708$9,763,127dollars as filed
ARVINAS INC04335A105COM388,766$9,575,307dollars as filed
MERUS N VN5749R100COM117,855$5,888,036dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS317,214$5,766,951dollars as filed
BICYCLE THERAPEUTICS PLC-ADR088786108SPONSORED ADS181,911$4,116,646dollars as filed
IMMATICS N.VN44445109SHS333,502$3,805,258dollars as filed
ADICET BIO INC007002108COM2,531,194$3,644,919dollars as filed
PRECISION BIOSCIENCES INC74019P207COM NEW381,803$3,420,955dollars as filed
REPARE THERAPEUTICS INC760273102COM989,364$3,403,412dollars as filed
SUTRO BIOPHARMA INC869367102COM762,498$2,638,243dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001591986-24-000007this filing2024-11-14acceptance time not in the bulk data set